| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35106-10ug | |||
| Carrier-Free | NBP2-35106-1mg | |||
| Carrier-Free | NBP2-35106-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11965-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12016-0.025mg | |||
![Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).](http://images.novusbio.com/fullsize/KAT3B-p300-Antibody-1H11G2-Chromatin-Immunoprecipitation-NBP2-59233-img0001.jpg "Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).")
![Immunohistochemistry-Paraffin: Estrogen Receptor Antibody (S21-V) [NBP1-30153] - human of breast tumor tissue stained with Estrogen Receptor antibody shows strong positive nuclear immunostaining.](http://images.novusbio.com/fullsize/108721_1.jpg "Immunohistochemistry-Paraffin: Estrogen Receptor Antibody (S21-V) [NBP1-30153] - human of breast tumor tissue stained with Estrogen Receptor antibody shows strong positive nuclear immunostaining.")
![Western Blot: AIBZIP Antibody [H00148327-D01P] - Analysis of CREB3L4 expression in transfected 293T cell line by CREB3L4 polyclonal antibody.Lane 1: CREB3L4 transfected lysate(43.40 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/AIBZIP-Antibody-Western-Blot-H00148327-D01P-img0003.jpg "Western Blot: AIBZIP Antibody [H00148327-D01P] - Analysis of CREB3L4 expression in transfected 293T cell line by CREB3L4 polyclonal antibody.Lane 1: CREB3L4 transfected lysate(43.40 KDa).Lane 2: Non-transfected lysate.")
![Western Blot: TRPM7 Antibody [NBP3-23362] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23362_rabbit-trpm7-pab-19920231252368.jpg "Western Blot: TRPM7 Antibody [NBP3-23362] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).")
![SDS-Page: Human NT-4 Protein [NBP2-35106]](http://images.novusbio.com/fullsize/Human-NT-4-Protein-SDS-Page-NBP2-35106-img0001.jpg "SDS-Page: Human NT-4 Protein [NBP2-35106]")
![SDS-Page: Recombinant Human FGF-17 Protein [NBP2-61312]](http://images.novusbio.com/fullsize/Recombinant-Human-FGF-17-Protein-SDS-Page-NBP2-61312-img0002.jpg "SDS-Page: Recombinant Human FGF-17 Protein [NBP2-61312]")
![Flow Cytometry: NMDAR2B Antibody (17) - Chimeric - BSA Free [NBP3-43544] - Paraformaldehyde fixed C6 cells permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-43544 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-43544_rabbit-nmdar2b-mab-17-chimeric-azide-and-bsa-free-7420252226524.png "Flow Cytometry: NMDAR2B Antibody (17) - Chimeric - BSA Free [NBP3-43544] - Paraformaldehyde fixed C6 cells permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-43544 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![Immunocytochemistry /Immunofluorescence: NMDAR2B Antibody (17) - Chimeric - BSA Free [NBP3-43544] - Immunofluorescence analysis of paraformaldehyde fixed C6 cells stained with NBP3-43544 at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-43544, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43544_rabbit-nmdar2b-mab-17-chimeric-azide-and-bsa-free-74202522141223.png)
![Immunocytochemistry/ Immunofluorescence: NMDAR2B Antibody (17) - BSA Free [NBP3-43543] - Immunofluorescence analysis of paraformaldehyde fixed C6 cells stained with NBP3-43543 at 10 µg/ml for 1h followed by Alexa Fluor® 488 secondary antibody (2 µg/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-43543, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43543_mouse-nmdar2b-mab-17-azide-and-bsa-free-immunocytochemistry-immunofluorescence-2220260322015.png "Immunocytochemistry/ Immunofluorescence: NMDAR2B Antibody (17) - BSA Free [NBP3-43543] - Immunofluorescence analysis of paraformaldehyde fixed C6 cells stained with NBP3-43543 at 10 µg/ml for 1h followed by Alexa Fluor® 488 secondary antibody (2 µg/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-43543, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.")
![Flow Cytometry: NMDAR2B Antibody (17) - BSA Free [NBP3-43543] - Paraformaldehyde fixed C6 cells permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-43543 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor® 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-43543_mouse-nmdar2b-mab-17-azide-and-bsa-free-flow-cytometry-222026035556.png)
![Western Blot: TRPM7 [p Ser1493] Antibody [NBP3-23179] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23179_rabbit-trpm7-p-ser1493-pab-11920231633161.jpg "Western Blot: TRPM7 [p Ser1493] Antibody [NBP3-23179] - Western blot image of human autophosphorylated TRPM7 C-terminal kinase domain (lanes 1-6). The blot was treated with lambda phosphatase to dephosphorylate TRPM7 phosphosites (lanes 2, 4, & 6). The blot was probed with rabbit polyclonals anti-TRPM7 (Ser-1513) phospho-specific (lanes 1 & 2), anti-TRPM7 (a.a.1484-1497) NBP3-23362 antibody (lanes 3 & 4), or anti-TRPM7 (Ser-1493) phospho-specific (lanes 5 & 6).")
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-IDEC-131-Toralizumab-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12016-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")